Utama › Kanser Paru-paru › Illinois › Joliet
Kajian klinikal Kanser Paru-paru di Joliet, IL
12 kajian untuk Kanser Paru-paru sedang mencari peserta di lokasi dalam dan sekitar Joliet (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
- UC Comprehensive Cancer Center at Silver Cross, New Lenox · 6 mi jauh
- University of Chicago Medicine-Orland Park, Orland Park · 14 mi jauh
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Mengambil pesertaFasa 3
- Northwestern Medicine Orland Park, Orland Park · 14 mi jauh
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Mengambil pesertaFasa 3
- Northwestern Medicine Orland Park, Orland Park · 14 mi jauh
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Mengambil pesertaFasa 2
- Hope and Healing Clinical Research, New Lenox · 6 mi jauh
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Hope and Healing Cancer Services, New Lenox · 6 mi jauh
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Mengambil pesertaFasa 2
- Hope and Healing Clinical Research, New Lenox · 6 mi jauh
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Mengambil pesertaFasa 3
- Hope and Healing Cancer Services, New Lenox · 6 mi jauh
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Mengambil pesertaFasa 1/2
- UC Comprehensive Cancer Center at Silver Cross, New Lenox · 6 mi jauh
- University of Chicago Medicine-Orland Park, Orland Park · 14 mi jauh
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- University of Chicago, New Lenox · 6 mi jauh
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Northwestern Medicine Orland Park, Orland Park · 14 mi jauh
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Northwestern Medicine Orland Park, Orland Park · 14 mi jauh
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2/3
- Northwestern Medicine Orland Park, Orland Park · 14 mi jauh
Kajian Kanser Paru-paru di bandar lain
- Houston, TX78 kajian
- Boston, MA62 kajian
- New York City, NY60 kajian
- Los Angeles, CA45 kajian
- Washington, DC41 kajian
- Arlington, VA41 kajian
- Chicago, IL41 kajian
- Nashville, TN40 kajian
- Baltimore, MD40 kajian
- St. Louis, MO39 kajian
- Columbus, OH37 kajian
- Philadelphia, PA36 kajian
Kajian lain di Joliet
- Kanser Paru-paru Bukan Sel Kecil12 kajian
- Kanser Metastatik7 kajian
- Kanser Pundi Kencing7 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher6 kajian
- Kanser Prostat5 kajian
- Kanser Hipofaring5 kajian
- Kanser Laring5 kajian
- Kanser Oral5 kajian
- Leukemia Mieloid Akut5 kajian
- Kanser Payudara4 kajian
- Kanser Kolon4 kajian
- Kanser Ginjal (Karsinoma Sel Renal)4 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.